BIO - Bio-Rad Laboratories, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 510.09B
Enterprise Value 39.64B
Trailing P/E 11.26
Forward P/E 138.57
PEG Ratio (5 yr expected) 12.24
Price/Sales (ttm)4.41
Price/Book (mrq)1.83
Enterprise Value/Revenue 34.21
Enterprise Value/EBITDA 627.40

Trading Information

Stock Price History

Beta (3Y Monthly) 1.35
52-Week Change 311.95%
S&P500 52-Week Change 33.10%
52 Week High 3345.50
52 Week Low 3220.05
50-Day Moving Average 3329.47
200-Day Moving Average 3310.44

Share Statistics

Avg Vol (3 month) 3182.3k
Avg Vol (10 day) 3214.55k
Shares Outstanding 524.7M
Float 21.27M
% Held by Insiders 114.62%
% Held by Institutions 178.00%
Shares Short (Aug 15, 2019) 4552.77k
Short Ratio (Aug 15, 2019) 42.59
Short % of Float (Aug 15, 2019) 42.57%
Short % of Shares Outstanding (Aug 15, 2019) 41.85%
Shares Short (prior month Jul 15, 2019) 4409.76k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/2
Last Split Date 3Mar 8, 2002

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin 39.54%
Operating Margin (ttm)9.45%

Management Effectiveness

Return on Assets (ttm)1.93%
Return on Equity (ttm)17.87%

Income Statement

Revenue (ttm)2.29B
Revenue Per Share (ttm)76.70
Quarterly Revenue Growth (yoy)-0.60%
Gross Profit (ttm)1.23B
EBITDA 351.73M
Net Income Avi to Common (ttm)904.8M
Diluted EPS (ttm)29.97
Quarterly Earnings Growth (yoy)123.40%

Balance Sheet

Total Cash (mrq)981.86M
Total Cash Per Share (mrq)32.94
Total Debt (mrq)661.07M
Total Debt/Equity (mrq)12.05
Current Ratio (mrq)4.68
Book Value Per Share (mrq)184.12

Cash Flow Statement

Operating Cash Flow (ttm)365.63M
Levered Free Cash Flow (ttm)230.62M